Cambodia begins to administer the Oxford–AstraZeneca COVID-19 vaccine as a third "booster" dose to people
Cambodia begins to administer the Oxford–AstraZeneca COVID-19 vaccine as a third "booster" dose to people who have received the inactivated virus vaccines developed by Sinopharm (BBIBP-CorV) and Sinovac (CoronaVac) in order to strengthen immunity against the SARS-CoV-2 Delta variant.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan to read this report and the complete Premium retrospective archive.
HealthCambodia begins to administer the Oxford–AstraZeneca COVID-19 vaccine as a third "booster" dose to people
View Premium plansBrowse free archive reportsCambodia begins to administer the Oxford–AstraZeneca COVID-19 vaccine as a third "booster" dose to people who have received the inactivated virus vaccines developed by Sinopharm (BBIBP-CorV) and Sinovac (CoronaVac) in order to strengthen immunity against the SARS-CoV-2 Delta variant.